The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Postmenopausal Osteoporosis
Abstract
Screening for osteoporosis is recommended in postmenopausal women on the basis of age and risk factors. Treatment approaches are determined by T score and the presence or risk of fracture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality after all major types of osteoporotic fracture in men and women: an observational study
Center, J. R., Nguyen, T. V., Schneider, D., Sambrook, P. N., & Eisman, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09075-8 · Cited by 1,926
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
Cosman, F., Crittenden, D. B., Adachi, J. D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L. C., Lau, E., Lewiecki, E. M., Miyauchi, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607948 · Cited by 1,805
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Saag, K. G., Petersen, J., Brandi, M. L., Karaplis, A. C., Lorentzon, M., Thomas, T., Maddox, J., Fan, M., Meisner, P. D., & Grauer, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708322 · Cited by 1,544
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010) · BMJ · doi:10.1136/bmj.c3691 · Cited by 1,099
Stone, K. L., Seeley, D. G., Lui, L.-Y., Cauley, J. A., Ensrud, K., Browner, W. S., Nevitt, M. C., & Cummings, S. R. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.11.1947 · Cited by 1,051
Bone, H. G., Wagman, R. B., Brandi, M. L., Brown, J. P., Chapurlat, R., Cummings, S. R., Czerwiński, E., Fahrleitner-Pammer, A., Kendler, D. L., Lippuner, K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30138-9 · Cited by 996
A critical review of the long-term disability outcomes following hip fracture
for the Fragility Fracture Network (FFN) Rehabilitation Research Special Interest Group, Dyer, S. M., Crotty, M., Fairhall, N., Magaziner, J., Beaupre, L. A., Cameron, I. D., & Sherrington, C. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0332-0 · Cited by 977
Miller, P. D., Hattersley, G., Riis, B. J., Williams, G. C., Lau, E., Russo, L. A., Alexandersen, P., Zerbini, C. A. F., Hu, M.-Y., Harris, A. G., et al. (2016) · JAMA · doi:10.1001/jama.2016.11136 · Cited by 875
Eastell, R., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Shoback, D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00221 · Cited by 868
Cummings, S. R., Ferrari, S., Eastell, R., Gilchrist, N., Jensen, J.-E. B., McClung, M., Roux, C., Törring, O., Valter, I., Wang, A. T., et al. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3337 · Cited by 734
Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1494 · Cited by 700
Adler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 672
Siris, E. S., Adler, R., Bilezikian, J., Bolognese, M., Dawson-Hughes, B., Favus, M. J., Harris, S. T., Jan de Beur, S. M., Khosla, S., Lane, N. E., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2655-z · Cited by 669
Hans, D., Goertzen, A. L., Krieg, M.-A., & Leslie, W. D. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.499 · Cited by 643
One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis
Black, D. M., Bilezikian, J. P., Ensrud, K. E., Greenspan, S. L., Palermo, L., Hue, T., Lang, T. F., McGowan, J. A., & Rosen, C. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050336 · Cited by 614
Brown, J. P., Prince, R. L., Deal, C., Recker, R. R., Kiel, D. P., de Gregorio, L. H., Hadji, P., Hofbauer, L. C., Álvaro-Gracia, J. M., Wang, H., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0809010 · Cited by 610
Leder, B. Z., Tsai, J. N., Uihlein, A. V., Wallace, P. M., Lee, H., Neer, R. M., & Burnett-Bowie, S.-A. M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61120-5 · Cited by 603
Kendler, D. L., Marin, F., Zerbini, C. A. F., Russo, L. A., Greenspan, S. L., Zikan, V., Bagur, A., Malouf-Sierra, J., Lakatos, P., Fahrleitner-Pammer, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32137-2 · Cited by 598
Langdahl, B. L., Libanati, C., Crittenden, D. B., Bolognese, M. A., Brown, J. P., Daizadeh, N. S., Dokoupilova, E., Engelke, K., Finkelstein, J. S., Genant, H. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31613-6 · Cited by 497
Tsai, J. N., Uihlein, A. V., Lee, H., Kumbhani, R., Siwila-Sackman, E., McKay, E. A., Burnett-Bowie, S.-A. M., Neer, R. M., & Leder, B. Z. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60856-9 · Cited by 496
Shoback, D., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Eastell, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa048 · Cited by 439
Samelson, E. J., Broe, K. E., Xu, H., Yang, L., Boyd, S., Biver, E., Szulc, P., Adachi, J., Amin, S., Atkinson, E., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30308-5 · Cited by 407
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
Black, D. M., Geiger, E. J., Eastell, R., Vittinghoff, E., Li, B. H., Ryan, D. S., Dell, R. M., & Adams, A. L. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916525 · Cited by 407
Guirguis-Blake, J. M., Michael, Y. L., Perdue, L. A., Coppola, E. L., & Beil, T. L. (2018) · JAMA · doi:10.1001/jama.2017.21962 · Cited by 400
Tsourdi, E., Zillikens, M. C., Meier, C., Body, J.-J., Gonzalez Rodriguez, E., Anastasilakis, A. D., Abrahamsen, B., McCloskey, E., Hofbauer, L. C., Guañabens, N., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa756 · Cited by 375
Barrionuevo, P., Kapoor, E., Asi, N., Alahdab, F., Mohammed, K., Benkhadra, K., Almasri, J., Farah, W., Sarigianni, M., Muthusamy, K., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00192 · Cited by 337
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
Shepstone, L., Lenaghan, E., Cooper, C., Clarke, S., Fong-Soe-Khioe, R., Fordham, R., Gittoes, N., Harvey, I., Harvey, N., Heawood, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32640-5 · Cited by 298
on behalf of the DAPS Investigators, Freemantle, N., Satram-Hoang, S., Tang, E.-T., Kaur, P., Macarios, D., Siddhanti, S., Borenstein, J., & Kendler, D. L. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1780-1 · Cited by 288
Osteoporosis or Low Bone Mass in Older Adults: United States, 2017-2018
Sarafrazi, N. (2021) · doi:10.15620/cdc:103477 · Cited by 273
Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
Finkelstein, J. S., Wyland, J. J., Lee, H., & Neer, R. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1703 · Cited by 265
Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States
Lewiecki, E. M., Ortendahl, J. D., Vanderpuye‐Orgle, J., Grauer, A., Arellano, J., Lemay, J., Harmon, A. L., Broder, M. S., & Singer, A. J. (2019) · JBMR Plus · doi:10.1002/jbm4.10192 · Cited by 241
Qaseem, A., Hicks, L. A., Etxeandia-Ikobaltzeta, I., Shamliyan, T., Cooney, T. G., & Clinical Guidelines Committee of the American College of Physicians (2023) · Annals of Internal Medicine · doi:10.7326/m22-1034 · Cited by 241
Black, D. M., Bauer, D. C., Vittinghoff, E., Lui, L.-Y., Grauer, A., Marin, F., Khosla, S., de Papp, A., Mitlak, B., Cauley, J. A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30159-5 · Cited by 228
Miller, P. D., Delmas, P. D., Lindsay, R., Watts, N. B., Luckey, M., Adachi, J., Saag, K., Greenspan, S. L., Seeman, E., Boonen, S., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0353 · Cited by 222
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524 · Cited by 208
The Association of Race, Gender, and Comorbidity With Mortality and Function After Hip Fracture
Penrod, J. D., Litke, A., Hawkes, W. G., Magaziner, J., Doucette, J. T., Koval, K. J., Silberzweig, S. B., Egol, K. A., & Siu, A. L. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.8.867 · Cited by 207
Lewiecki, E. M., Dinavahi, R. V., Lazaretti-Castro, M., Ebeling, P. R., Adachi, J. D., Miyauchi, A., Gielen, E., Milmont, C. E., Libanati, C., & Grauer, A. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3622 · Cited by 207
Hip Fracture and Increased Short-term but Not Long-term Mortality in Healthy Older Women
LeBlanc, E. S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.447 · Cited by 198
Osteoporosis, frailty and fracture: implications for case finding and therapy
van den Bergh, J. P., van Geel, T. A., & Geusens, P. P. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.217 · Cited by 179
Trends in osteoporosis and low bone mass in older US adults, 2005–2006 through 2013–2014
Looker, A. C., Sarafrazi Isfahani, N., Fan, B., & Shepherd, J. A. (2017) · Osteoporosis International · doi:10.1007/s00198-017-3996-1 · Cited by 178
McCloskey, E. V., Johansson, H., Odén, A., Austin, M., Siris, E. S., Wang, A., Lewiecki, E. M., Lorenc, R. S., Libanati, C. R., & Kanis, J. А. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1606 · Cited by 144
Cosman, F., Huang, S., McDermott, M., & Cummings, S. R. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4705 · Cited by 131
Lyu, H., Yoshida, K., Zhao, S. S., Wei, J., Zeng, C., Tedeschi, S. K., Leder, B. Z., Lei, G., Tang, P., & Solomon, D. H. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0882 · Cited by 120
Romosozumab and antiresorptive treatment: the importance of treatment sequence
Cosman, F., Kendler, D. L., Langdahl, B. L., Leder, B. Z., Lewiecki, E. M., Miyauchi, A., Rojeski, M., McDermott, M., Oates, M. K., Milmont, C. E., et al. (2022) · Osteoporosis International · doi:10.1007/s00198-021-06174-0 · Cited by 120
Gilsenan, A., Midkiff, K. D., Harris, D., Kellier‐Steele, N., McSorley, D., & Andrews, E. B. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4188 · Cited by 111
Nonresponders to Osteoporosis Therapy
Lewiecki, E. M. (2003) · Journal of Clinical Densitometry · doi:10.1385/jcd:6:4:307 · Cited by 104
Makras, P., Appelman‐Dijkstra, N. M., Papapoulos, S. E., van Wissen, S., Winter, E. M., Pοlyzos, S. A., Yavropoulou, M. P., & Anastasilakis, A. D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab321 · Cited by 71
Hoffmann, I., Kohl, M., von Stengel, S., Jakob, F., Kerschan-Schindl, K., Lange, U., Peters, S., Schoene, D., Sieber, C., Thomasius, F., et al. (2023) · Osteoporosis International · doi:10.1007/s00198-022-06592-8 · Cited by 49
Siu, A. L., Allore, H. G., Brown, D., Charles, S. T., & Lohman, M. C. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0961 · Cited by 35
Operationalizing Treat-to-Target for Osteoporosis
Lewiecki, E. M. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.970 · Cited by 17
Cited by
Karakasis, P., Patoulias, D., Fragakis, N., & Mantzoros, C. S. (2025) · Metabolism · doi:10.1016/j.metabol.2024.156113 · Cited by 242
Metadata
- Authors
- Walker, M. D., & Shane, E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-11-23
- Volume
- 389
- Issue
- 21
- Pages
- 1979-1991
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4388892353
- Cited by
- 381
- References
- 54
- FWCI
- 99.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.